163 related articles for article (PubMed ID: 35043749)
1. Palliative Radiotherapy for Esophageal and Gastric Cancer: Population-Based Patterns of Utilization and Outcomes in Ontario, Canada.
Merchant SJ; Kong W; Mahmud A; Booth CM; Hanna TP
J Palliat Care; 2023 Apr; 38(2):157-166. PubMed ID: 35043749
[TBL] [Abstract][Full Text] [Related]
2. First-Line Palliative Chemotherapy for Esophageal and Gastric Cancer: Practice Patterns and Outcomes in the General Population.
Merchant SJ; Kong W; Gyawali B; Hanna TP; Chung W; Nanji S; Patel SV; Booth CM
JCO Oncol Pract; 2021 Oct; 17(10):e1537-e1550. PubMed ID: 33449833
[TBL] [Abstract][Full Text] [Related]
3. Palliative Radiotherapy in the Presence of Well-Controlled Metastatic Disease after Initial Chemotherapy May Prolong Survival in Patients with Metastatic Esophageal and Gastric Cancer.
Hingorani M; Dixit S; Johnson M; Plested V; Alty K; Colley P; Beavis AW; Roy R; Maraveyas A
Cancer Res Treat; 2015 Oct; 47(4):706-17. PubMed ID: 25687854
[TBL] [Abstract][Full Text] [Related]
4. Factors affecting the use of palliative radiotherapy in Ontario.
Huang J; Zhou S; Groome P; Tyldesley S; Zhang-Solomans J; Mackillop WJ
J Clin Oncol; 2001 Jan; 19(1):137-44. PubMed ID: 11134206
[TBL] [Abstract][Full Text] [Related]
5. Variation in palliative care of esophageal cancer in clinical practice: factors associated with treatment decisions.
Opstelten JL; de Wijkerslooth LR; Leenders M; Bac DJ; Brink MA; Loffeld BC; Meijnen-Bult MJ; Minderhoud IM; Verhagen MA; van Oijen MG; Siersema PD
Dis Esophagus; 2017 Feb; 30(2):1-7. PubMed ID: 26919349
[TBL] [Abstract][Full Text] [Related]
6. Variation in Diagnosis, Treatment, and Outcome of Esophageal Cancer in a Regionalized Care System in Ontario, Canada.
Habbous S; Yermakhanova O; Forster K; Holloway CMB; Darling G
JAMA Netw Open; 2021 Sep; 4(9):e2126090. PubMed ID: 34546371
[TBL] [Abstract][Full Text] [Related]
7. Symptom Evolution in Patients with Esophageal and Gastric Cancer Receiving Palliative Chemotherapy: A Population-Based Study.
Merchant SJ; Kong W; Brundage M; Booth CM
Ann Surg Oncol; 2021 Jan; 28(1):79-87. PubMed ID: 33140252
[TBL] [Abstract][Full Text] [Related]
8. Factors influencing access to palliative radiotherapy: a Norwegian population-based study.
Åsli LM; Myklebust TÅ; Kvaløy SO; Jetne V; Møller B; Levernes SG; Johannesen TB
Acta Oncol; 2018 Sep; 57(9):1250-1258. PubMed ID: 29706109
[TBL] [Abstract][Full Text] [Related]
9. Estimating the need for palliative radiotherapy for brain metastasis: a benchmarking approach.
Kong W; Jarvis C; Mackillop WJ
Clin Oncol (R Coll Radiol); 2015 Feb; 27(2):83-91. PubMed ID: 25481789
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcomes of palliative treatment for gastric bleeding from incurable gastric cancer.
Yagi S; Ida S; Namikawa K; Hayami M; Makuuchi R; Kumagai K; Ohashi M; Sano T; Nunobe S
Surg Today; 2023 Mar; 53(3):360-368. PubMed ID: 35932300
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of a model predicting short survival (death within 30 days) after palliative radiotherapy.
Angelo K; Norum J; Dalhaug A; Pawinski A; Aandahl G; Haukland E; Engljähringer K; Nieder C
Anticancer Res; 2014 Feb; 34(2):877-85. PubMed ID: 24511026
[TBL] [Abstract][Full Text] [Related]
12. Palliative radiotherapy delivery by a dedicated multidisciplinary team facilitates early integration of palliative care: A secondary analysis of routinely collected health data.
Fairchild A; Hill J; Alhumaid M; Rau A; Ghosh S; Le A; Watanabe SM
J Med Imaging Radiat Sci; 2022 Jun; 53(2 Suppl):S51-S55. PubMed ID: 35210177
[TBL] [Abstract][Full Text] [Related]
13. Short course palliative radiotherapy of 20 Gy in 5 fractions for advanced and incurable head and neck cancer: AIIMS study.
Mohanti BK; Umapathy H; Bahadur S; Thakar A; Pathy S
Radiother Oncol; 2004 Jun; 71(3):275-80. PubMed ID: 15172142
[TBL] [Abstract][Full Text] [Related]
14. Combined stent insertion and single high-dose brachytherapy in patients with advanced esophageal cancer--results of a prospective safety study.
Bergquist H; Johnsson E; Nyman J; Rylander H; Hammerlid E; Friesland S; Ejnell H; Lundell L; Ruth M
Dis Esophagus; 2012 Jul; 25(5):410-5. PubMed ID: 21899654
[TBL] [Abstract][Full Text] [Related]
15. A population-based study of the fractionation of palliative radiotherapy for bone metastasis in Ontario.
Kong W; Zhang-Salomons J; Hanna TP; Mackillop WJ
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1209-17. PubMed ID: 17967310
[TBL] [Abstract][Full Text] [Related]
16. Outcome of palliative esophageal stenting for malignant dysphagia: a retrospective analysis.
Burstow M; Kelly T; Panchani S; Khan IM; Meek D; Memon B; Memon MA
Dis Esophagus; 2009; 22(6):519-25. PubMed ID: 19302213
[TBL] [Abstract][Full Text] [Related]
17. Estimating the Need for Palliative Radiation Therapy: A Benchmarking Approach.
Mackillop WJ; Kong W
Int J Radiat Oncol Biol Phys; 2016 Jan; 94(1):51-59. PubMed ID: 26700702
[TBL] [Abstract][Full Text] [Related]
18. Collaborating with the Community: Improving Patient Access to Palliative Radiation Therapy.
Loudon J; Rozanec N; Clement A; Woo R; Grant A; Murray J; Wells W
Pract Radiat Oncol; 2020; 10(1):1-7. PubMed ID: 31437605
[TBL] [Abstract][Full Text] [Related]
19. Palliative Appropriateness Criteria: A Pragmatic Method to Evaluate the Suitability of Palliative Radiotherapy Fractionation.
Farris JC; Johnson AG; Carriere PP; Patel ZA; Nagatsuka M; Farris MK; Hughes RT
J Palliat Med; 2023 Jan; 26(1):67-72. PubMed ID: 35881861
[No Abstract] [Full Text] [Related]
20. Palliative radiotherapy utilization for cancer patients at end of life in British Columbia: retrospective cohort study.
Huang J; Wai ES; Lau F; Blood PA
BMC Palliat Care; 2014; 13(1):49. PubMed ID: 25419181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
